This is a virtual study and you can participate in the comfort and safety of your own home. Participation involves receiving 8 mindfulness practice sessions that includes both live ZOOM delivered sessions and pre-recorded video sessions. Questionnaires will be completed by the subject. Study lasts for about 16 weeks and there is compensation. Read More
1) Adults (>18 years)
2) Pulmonary Hypertension confirmed by standard guidelines,
3) Self-identified as underserved racial minority person,
4) Willingness to participate in the mindfulness practice program for the duration of the study period
5) Able to ambulate independently,
7) Have access to a mobile phone.
Participants 1-24 months old at Oishei Children's Hospital Emergency Deparment (ED) with suspected Bronchiolitis may be eligible for this study. Once enrolled, participants will undergo two carbon dioxide measurements, first will be done upon ED arrival at the Triage room, and the second one will be done upon ED discharge at patient's private room. Otherwise, participant will receive routine clinical care. Read More
Children ages 1-24 months old.
Have respiratory signs and symptoms and suspected bronchiolitis.
This study is for COPD patients 40 years and older who have been hospitalized and discharged within 90 days. These patients will be interviewed and take a one-time survey which takes 30-45 minutes. Read More
1) Age ≥40 years
2) GOLD stage ≥2, FEV1 <80% predicted
3) Hospitalized for an acute exacerbation for COPD
4) Discharged from the hospital setting within 90 days of the AECOPD
Caregivers: We will ask COPD patients to identify caregivers who might also be willing to participate in the caregiver interviews. A caregiver will be defined as a family me...
This study enrolls adults who have had a positive test for COVID-19. The purpose of this study is to learn more about how the infection works, including how the virus evolves and how a person infected with COVID-19's body responds. Knowing more about the virus at a cellular level will help scientists develop better treatments for this devastating disease. Read More
-Positive for COVID-19
-We will restrict asymptomatic enrollees to a maximum of 20% (100) participants. Once that number is achieved, symptoms of COVID-19 will be required for inclusion in to the study.
This study enrolls children ages 5-17 with asthma. The purpose of this research study is to find out if a breathing test called FeNO changes how doctors decide to treat your asthma. The FeNO test measures the amount of nitric oxide in the air you slowly breath out of your lungs and is a test for inflammation in the lungs. The FeNO test can also help doctors determine how well your asthma medications are suppressing inflammation in the lungs. Read More
Children ages 5-17.
Diagnosis of asthma.
Patients of the UBMD Pediatrics Allergy/Immunology clinic.
This study enrolls premature babies with apnea in the NICU who have been treated with caffeine medication. The purpose of this study is to find out if continuing caffeine will help babies be discharged sooner. Read More
Children- babies born prematurely between 29-33 weeks gestation.
Have been diagnosed with apnea.
Have been treated with caffeine.
Are currently in the Neonatal Intensive Care Unit (NICU).
We are looking for children age 7-16 years old with asthma and their parents for a research study. The purpose of this study is to find out if children and their parents have different or similar opinions on how much their child’s asthma affects their everyday life. Read More
This study enrolls infants who are admitted to Oishei Children's hospital's Pediatric Intensive Care Unit (PICU) with bronchiolitis. The purpose of this study is to see how a medication for the condition compares with usual care. Read More
Children (infants) less than 8 months of age.
Admitted to PICU with bronchiolitis.